The active substance in Wegovy, semaglutide, is a ‘GLP-1 receptor agonist’.
It acts in the same way as GLP-1 (a natural hormone in the body) and, among other things, appears to regulate appetite by increasing a person’s feelings of fullness, while reducing their food intake, hunger and cravings.
Further information on Wegovy is available in the in the Summary of Product Characteristics from the European Medicines Agency which is available here
How does Wegovy work?
Updated over 2 months ago